Want to join the conversation?
$ABT's R&D expenses increased by 23.7% in 3Q15, due primarily to higher spending across its various businesses and the impact of higher restructuring costs recorded in the quarter. SG&A expenses for 3Q15 increased 4.5%, due primarily to the impact of the acquisition of CFR Pharmaceuticals in 3Q14 and Veropharm in 4Q14.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!